Ofloxacin (Tarivid)

Ofloxacin (Tarivid) is an approved antibiotic that is used for the treatment of a variety of common bacterial infections. It may be useful in combination with other drugs as a treatment for multi-drug resistant tuberculosis.1 Side-effects can include gastrointestinal problems, headache, anxiety, tremulousness and thrush.

Ofloxacin does not interact with any currently available protease inhibitors or non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Ofloxacin comes in the form of tablets or a liquid for intravenous infusion. It is manufactured by Hoechst-Roussel Pharmaceuticals. In the United States its trade name is Floxin.

References

  1. Sharma SK et al. Effect of additional oral ofloxacin administration in the treatment of multidrug-resistant tuberculosis. Indian J Chest Dis Allied Sci 38: 73-79, 1996

Up a level
Back to contents
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.